Factores de riesgo para recaída de tuberculosis pulmonar en pacientes del Hospital Santa Clara de Bogotá 1992/2000
Factores de riesgo para recaída de tuberculosis pulmonar en pacientes del Hospital Santa Clara de Bogotá 1992/2000

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Show authors biography
Pulmonary tuberculosis relapse is defined as these patients that make recurrence of tuberculosis after complete an adequate treatment, and these patients are again diagnosed bacteriologically with tuberculosis. We tried to identify the risk factors for relapse among adults, through an analitical study of cases and controls, with eighty patients among the tuberculosis programme of Santa Clara Hospital between 1992-2000 with relapse diagnosis which meet criterion of case and eighty patients which meet criterion of control. We did a bivariate analysis with confidence intervals and univariate calculation with logistic regression analysis to predict the development of relapse for the different variables.
Results : We found that the next variables are joined with relapse, alcoholism with OR 2.6 IC 1.063-6.42, addicted to smoking OR 2.2 IC 1.066-6.457, extrapulmonary compromise OR 2.4 IC 1.7-2.4, two or more lobules compromised OR 8.5 IC 3.9-18, pleural thickened OR 3.1 IC 1.3-7.4, fibrothorax OR 10 IC 2.3-47.2.
Diabetes mellitus, chronic renal failure, silicosis are associated with relapse, but in our study we found another facotrs which are joined to relapse and we suggest that if we find these factors among tuberculosis patients would indicate the chance of relapse and this would create the necessity of use a larger number of doses of antituberculosis medicaments.
Article visits 3 | PDF visits 1
Downloads
- Pilheu JA. Tuberculosis 2000 problems and solutions. /nt J Tuberc Lung Dis 1998; 2: 696-703.
- Schwoebel V, Antoine D, Veen J. Surveillance of tuberculosis in Europe. Med Arch 1999; 53: 95-10S.
- Harries AD, Hargreaves NJ, Kwanjana JH. Recurrent tuberculosis : definitions and retreatment regimens 1999; 3: 851-4.
- Bandera, Gori. Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol 2001; 39: 2213-18.
- Van Rie A, Warren R. Exogenous reinfection as a cause of recurrent tuberculosis after a curative treatment. NEJM 1999; 14: 1174-9.
- Chang J,Kim S. Diagnostic issues in tuberculosis of the ribs with a review of 12 surgically proven cases. Respirology 1999; 4: 249-53.
- Fandiño F, Kritski A (1999) Drug resistance patterns among hospitalized tuberculous patients in Rio de Janeiro Brazil 1993-94. Mem Inst Oswaldo Cruz 4,543-7.
- Elikin Av, Savin Ib (1999) External respiratory function and pulmonary capillary blood. flow in patients with postoperative recurrent pulmonary tuberculosis. Prob/Tuberk 3,16-9.
- Lius, Ellis (1999). Predictors of sputum culture conversion among patients with tuberculosis in the era of tuberculosis resurgence. Arch Intern Med, 24, 159,10, 1110.
- Taylor J, Bergmire S (1999). Epidemiology of drug resistant tuberculosis in Texas. Am J Epidem 15,149,4,359-65.
- Hyncicova | (1998). Molecular epidemiology of tuberculosis. Epidemiol Mykrobiol imunol 47,2,68-71.
- Laraja M, Screm C (1997).Antituberculous drug resistance surveillance as a tool for tuberculosis control programmes: a retrospective study. Monaldi Ach Chest Dis 52,5,450-4.
- Shikhaher 1.(1997). Non traditional methods for prevention of recurrent tuberculosis. Prob/ Tuberk 3, 14-7.
- Gavrilenko vs, Khruleva. (1996).The current aspects of the recurrence of tuberculosis of the respiratory system in adults. Probl Tuberk 4,2-4.
- Wang, Ling.(2001) Drug resistant tuberculosis in Taipei. Am J Infect Control 29,1,41-7
- Oliveira, Moreira.(2000). Treatment abandonment and tubeculosis recurrence :aspects of previous episodes, Brazil 19934 Rev Saude Publica 34,5, 437-43.
- Fitzgerald, Desvarieux (2000). Effect of posttreatment isoniazid on prevention of recurrent tuberculosis en HIV1 infected individuals: a randomised trial. Lancet 28,356,9240,1470-4.
- Banda H, Kangiombe (2000) Mortality rates and recurrent rates of tuberculosis in patients with smearnegative pulmonary tuberculosis and tuberculosis pleural effusion who have completed treatment. Int J tuberc lung dis 4,10,968-74
- Harries A, Hargreaves N (2000) Relapse and recurrent tuberculosis in the contexotf a national tuberculosis control programme. Trans R Soc Trop Med Hyg, 94,3,247-9.
- Hnizdo E, Singh T. (2000). Crhronic pulmonary function impairment cause by initial and recurrent pulmonary tuberculosis following treatment. Thorax 55,1,32-8.
- Eisaev B (1995) results of the treatment of patients with recurrence of pulmonary tuberculosis with different types of haptoglobin. Probl Tuberk, 6, 20-2
- Okwera A, Whalen C.(1994) Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV infected ugandans. The Makenere univesty-care. Lancet 12,344,8933,1323-8.
- Gavrilenko, Tavolzhaskii(1993), Incidence and duration of recurrence of respiratory tuberculosis in adults. Probl Tuberk 2, 10-3.
- Kado, Isobe. Clinical feature of the diabetic patients with recurrent pulmonary tuberculosis. Kekkaku 1992; 67: 313-8.
- Radenbach D. Recurrence of lung tuberculosis. Pneumologie 1990; 44, 1501S.
- Biron MG. The risk of reactivation of posttuberculosis changes in patients with severe somatic diseases. Prob/Tuberk 1990; 3: 13-16.
- Kopanoff, Snider. Recurrent tuberculosis: Why do patients develop disease again? A United States Public Health Serve Cooperative Survey. Am J Public Health 1988; 78: 30-3.
- Small P. Fiujimura P. Management of tuberculosis in the USA. Review article.NEJM 2001; 345: 189-208
- Boer. Recurrent Tuberculosis due to exogenous reinfection.NEJM 2000; 342: 1050-1.
- Gelband (2000).Regimens of less than 6 months for treating tuberculosis. Cochrane database syst rev 2,cd09312.
- DGDu Plessis. Demonstration of reinfection and reactivation in HIV negative autopsied cases of secondary TBC :DNA fingerprinting 7BC 2001; 81: 211-20.